Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Edgerton

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancerS Liu, S M Edgerton, D H Moore, et al.
International Journal of Cancer|September 9, 1992
pS2 protein and steroid hormone receptors in invasive breast carcinomasF C Koerner, D E Goldberg, S M Edgerton, et al.
Breast Cancer Research and Treatment|August 10, 2000
p(21WAF1/CIP1) expression in breast cancers: associations with p53 and outcomeA D Thor, S Liu, D H Moore, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|March 6, 1999
Long-term outcome analysis of two treatment methods for cleft palate: combined levator retropositioning and pharyngeal flap versus double-opposing Z-plastyK Y Lin, D Goldberg, C Williams, et al.
Journal of Oncology Translational Research|May 22, 2018
Metformin Targets Glucose Metabolism in Triple Negative Breast CancerR S Wahdan-Alaswad, S M Edgerton, H S Salem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancersA D Thor, S M Edgerton, S Liu, et al.
Journal of Dental Research|January 1, 2003
Evidence-based practice in dentistry: benefit or hindranceF Chiappelli, P Prolo, M Newman, et al.
Human Pathology|February 10, 2000
Invasive micropapillary carcinoma of the breast: a prognostic studyM Paterakos, W G Watkin, S M Edgerton, et al.
International Journal of Clinical and Experimental Pathology|August 12, 2015
Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cellsHui Lyu, Jingcao Huang, Susan M Edgerton, et al.
International Journal of Cancer|February 3, 2007
Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cellsBolin Liu, Dalia Ordonez-Ercan, Zeying Fan, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancerS Liu, S M Edgerton, D H Moore, et al.
International Journal of Cancer|September 9, 1992
pS2 protein and steroid hormone receptors in invasive breast carcinomasF C Koerner, D E Goldberg, S M Edgerton, et al.
Breast Cancer Research and Treatment|August 10, 2000
p(21WAF1/CIP1) expression in breast cancers: associations with p53 and outcomeA D Thor, S Liu, D H Moore, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|March 6, 1999
Long-term outcome analysis of two treatment methods for cleft palate: combined levator retropositioning and pharyngeal flap versus double-opposing Z-plastyK Y Lin, D Goldberg, C Williams, et al.
Journal of Oncology Translational Research|May 22, 2018
Metformin Targets Glucose Metabolism in Triple Negative Breast CancerR S Wahdan-Alaswad, S M Edgerton, H S Salem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancersA D Thor, S M Edgerton, S Liu, et al.
Journal of Dental Research|January 1, 2003
Evidence-based practice in dentistry: benefit or hindranceF Chiappelli, P Prolo, M Newman, et al.
Human Pathology|February 10, 2000
Invasive micropapillary carcinoma of the breast: a prognostic studyM Paterakos, W G Watkin, S M Edgerton, et al.
International Journal of Clinical and Experimental Pathology|August 12, 2015
Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cellsHui Lyu, Jingcao Huang, Susan M Edgerton, et al.
International Journal of Cancer|February 3, 2007
Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cellsBolin Liu, Dalia Ordonez-Ercan, Zeying Fan, et al.
Pageof 9